Differential adipokine response in genetically predisposed lean and obese rats during inflammation: A role in modulating experimental colitis?

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 297, Issue 5, 2009, Pages

  Hyland, Niall P ^a,b   Chambers, Adam P ^a   Keenan, Catherine M ^a   Pittman, Quentin J ^a   Sharkey, Keith A ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

Adiponectin; Body weight; Diet induced obese; Ghrelin; Leptin; Plasminogen activator inhibitor 1

Indexed keywords

ADIPONECTIN; BIOLOGICAL MARKER; GHRELIN; INSULIN; LEPTIN; MYELOPEROXIDASE; PLASMINOGEN ACTIVATOR INHIBITOR 1; SODIUM CHLORIDE; TRINITROBENZENESULFONIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; C57BL 6 MOUSE; CELL FUNCTION; COLITIS; COLON INJURY; COLON MUCOSA; COLON ULCER; CONTROLLED STUDY; ENZYME ACTIVITY; FOOD INTAKE; GENETIC PREDISPOSITION; HISTOLOGY; INSULIN BLOOD LEVEL; KNOCKOUT MOUSE; MALE; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; RAT; SCORING SYSTEM; WEIGHT REDUCTION;

ADIPOKINES; ADIPONECTIN; ANIMALS; BODY WEIGHT; COLITIS, ULCERATIVE; COLON; EATING; ELECTRIC IMPEDANCE; ELECTROPHYSIOLOGICAL PHENOMENA; GENETIC PREDISPOSITION TO DISEASE; GHRELIN; INFLAMMATION; INSULIN; LEPTIN; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OBESITY; PEROXIDASE; PLASMINOGEN ACTIVATOR INHIBITOR 1; RATS; RATS, INBRED STRAINS; SERPINS; THINNESS; TRINITROBENZENESULFONIC ACID;

EID: 72249086071     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.00164.2009     Document Type: Article

References (48)

1. Alessi MC, Peiretti F, Morange P, Henry M, Nalbone G, Juhan-Vague I. Production of plasminogen activator inhibitor 1 by human adipose tissue: possible link between visceral fat accumulation and vascular disease. Diabetes 46: 860-867, 1997. (Pubitemid 27188265)
2. Asakura H, Suzuki K, Kitahora T, Morizane T. Is there a link between food and intestinal microbes and the occurrence of Crohn's disease and ulcerative colitis? J Gastroenterol Hepatol 23: 1794 - 1801, 2008.
3. Backhed F, Manchester JK, Semenkovich CF, Gordon JI. Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proc Natl Acad Sci USA 104: 979-984, 2007. (Pubitemid 46154722)
4. Barbier M, Cherbut C, Aube AC, Blottiere HM, Galmiche JP. Elevated plasma leptin concentrations in early stages of experimental intestinal inflammation in rats. Gut 43: 783-790, 1998. (Pubitemid 28539657)
5. Baumgart DC, Carding SR. Inflammatory bowel disease: cause and immunobiology. Lancet 369: 1627-1640, 2007. (Pubitemid 46722636)
6. Berni CR, Terrin G, Borrelli O, Romano MT, Manguso F, Coruzzo A, D'Armiento F, Romeo EF, Cucchiara S. Short- and long-term therapeutic efficacy of nutritional therapy and corticosteroids in paediatric Crohn's disease. Dig Liver Dis 38: 381-387, 2006. (Pubitemid 44356207)
7. Blundell JE, Stubbs RJ, Golding C, Croden F, Alam R, Whybrow S, Le NJ, Lawton CL. Resistance and susceptibility to weight gain: individual variability in response to a high-fat diet. Physiol Behav 86: 614-622, 2005. (Pubitemid 41728979)
8. Brun P, Castagliuolo I, Leo VD, Buda A, Pinzani M, Palu G, Martines D. Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis. Am J Physiol Gastrointest Liver Physiol 292: G518-G525, 2007. (Pubitemid 46263521)
9. Cakir B, Bozkurt A, Ercan F, Yegen BC. The anti-inflammatory effect of leptin on experimental colitis: involvement of endogenous glucocorticoids. Peptides 25: 95-104, 2004. (Pubitemid 38304946)
10. Conlan MG, Haire WD, Burnett DA. Prothrombotic abnormalities in inflammatory bowel disease. Dig Dis Sci 34: 1089-1093, 1989. (Pubitemid 19188892)
11. Danese S, Papa A, Saibeni S, Repici A, Malesci A, Vecchi M. Inflammation and coagulation in inflammatory bowel disease: the clot thickens. Am J Gastroenterol 102: 174-186, 2007. (Pubitemid 46072059)
12. De Smet B, Thijs T, Moechars D, Colsoul B, Polders L, Ver DL, Coulie B, Peeters TL, Depoortere I. Endogenous and exogenous ghrelin enhance the colonic and gastric manifestations of dextran sodium sulphate-induced colitis in mice. Neurogastroenterol Motil 21: 59-70, 2009.
13. de Jong E, Porte RJ, Knot EA, Verheijen JH, Dees J. Disturbed fibrinolysis in patients with inflammatory bowel disease. A study in blood plasma, colon mucosa, and faeces. Gut 30: 188-194, 1989. (Pubitemid 19058871)
14. Desreumaux P, Huet G, Zerimech F, Gambiez L, Balduyck M, Baron P, Degand P, Cortot A, Colombel JF, Janin A. Acute inflammatory intestinal vascular lesions and in situ abnormalities of the plasminogen activation system in Crohn's disease. Eur J Gastroenterol Hepatol 11: 1113-1119, 1999. (Pubitemid 30433761)
15. Fayad R, Pini M, Sennello JA, Cabay RJ, Chan L, Xu A, Fantuzzi G. Adiponectin deficiency protects mice from chemically induced colonic inflammation. Gastroenterology 132: 601-614, 2007. (Pubitemid 46274660)
16. Friedman JM, Halaas JL. Leptin and the regulation of body weight in mammals. Nature 395: 763-770, 1998. (Pubitemid 28485436)
17. Gimeno RE, Klaman LD. Adipose tissue as an active endocrine organ: recent advances. Curr Opin Pharmacol 5: 122-128, 2005.
18. Gonzalez-Rey E, Chorny A, Delgado M. Therapeutic action of ghrelin in a mouse model of colitis. Gastroenterology 130: 1707-1720, 2006. (Pubitemid 43668852)
19. Gorski JN, Dunn-Meynell AA, Levin BE. Maternal obesity increases hypothalamic leptin receptor expression and sensitivity in juvenile obesity-prone rats. Am J Physiol Regul Integr Comp Physiol 292: R1782-R1791, 2007.
20. Hotamisligil GS. Inflammation and metabolic disorders. Nature 444: 860-867, 2006.
21. Hutley L, Prins JB. Fat as an endocrine organ: relationship to the metabolic syndrome. Am J Med Sci 330: 280-289, 2005. (Pubitemid 41831898)
22. Janand-Delenne B, Chagnaud C, Raccah D, Alessi MC, Juhan-Vague I, Vague P. Visceral fat as a main determinant of plasminogen activator inhibitor 1 level in women. Int J Obes Relat Metab Disord 22: 312-317, 1998. (Pubitemid 28138436)
23. John BJ, Irukulla S, Abulafi AM, Kumar D, Mendall MA. Systematic review: adipose tissue, obesity and gastrointestinal diseases. Aliment Pharmacol Ther 23: 1511-1523, 2006. (Pubitemid 43727458)
24. Kouris-Blazos A, Wahlqvist ML. Health economics of weight management: evidence and cost. Asia Pac J Clin Nutr, 16 Suppl 1: 329-338, 2007.
25. Levin BE, Dunn-Meynell AA. Differential effects of exercise on body weight gain and adiposity in obesity-prone and -resistant rats. Int J Obes (Lond) 30: 722-727, 2006.
26. Levin BE, Dunn-Meynell AA, Balkan B, Keesey RE. Selective breeding for diet-induced obesity and resistance in Sprague-Dawley rats. Am J Physiol Regul Integr Comp Physiol 273: R725-R730, 1997. (Pubitemid 27428089)
27. Levin BE, Dunn-Meynell AA, Ricci MR, Cummings DE. Abnormalities of leptin and ghrelin regulation in obesity-prone juvenile rats. Am J Physiol Endocrinol Metab 285: E949-E957, 2003.
28. Levin BE, Hogan S, Sullivan AC. Initiation and perpetuation of obesity and obesity resistance in rats. Am J Physiol Regul Integr Comp Physiol 256: R766-R771, 1989.
29. Ley RE, Backhed F, Turnbaugh P, Lozupone CA, Knight RD, Gordon JI. Obesity alters gut microbial ecology. Proc Natl Acad Sci USA 102: 11070-11075, 2005. (Pubitemid 41105994)
30. Li S, Zhang HY, Hu CC, Lawrence F, Gallagher KE, Surapaneni A, Estrem ST, Calley JN, Varga G, Dow ER, Chen Y. Assessment of diet-induced obese rats as an obesity model by comparative functional genomics. Obesity (Silver Spring) 16: 811-818, 2008.
31. Ma X, Torbenson M, Hamad AR, Soloski MJ, Li Z. High-fat diet modulates non-CD1d-restricted natural killer T cells and regulatory T cells in mouse colon and exacerbates experimental colitis. Clin Exp Immunol 151: 130-138, 2008. (Pubitemid 350230983)
32. McCafferty DM, Wallace JL, Sharkey KA. Effects of chemical sympathectomy and sensory nerve ablation on experimental colitis in the rat. Am J Physiol Gastrointest Liver Physiol 272: G272-G280, 1997. (Pubitemid 27137240)
33. Michel C, Dunn-Meynell A, Levin BE. Reduced brain CRH and GR mRNA expression precedes obesity in juvenile rats bred for diet-induced obesity. Behav Brain Res 154: 511-517, 2004. (Pubitemid 39094002)
34. Nishihara T, Matsuda M, Araki H, Oshima K, Kihara S, Funahashi T, Shimomura I. Effect of adiponectin on murine colitis induced by dextran sulfate sodium. Gastroenterology 131: 853-861, 2006. (Pubitemid 44307068)
35. Oishi K, Ohkura N, Matsuda J, Ishida N. Food deprivation induces adipose plasminogen activator inhibitor-1 (PAI-1) expression without accumulation of plasma PAI-1 in genetically obese and diabetic db/db mice. Thromb Haemost 98: 864-870, 2007. (Pubitemid 47555081)
36. Papathanassoglou E, El-Haschimi K, Li XC, Matarese G, Strom T, Mantzoros C. Leptin receptor expression and signaling in lymphocytes: kinetics during lymphocyte activation, role in lymphocyte survival, and response to high fat diet in mice. J Immunol 176: 7745-7752, 2006. (Pubitemid 43849075)
37. Paul G, Schaffler A, Neumeier M, Furst A, Bataillle F, Buechler C, Muller-Ladner U, Scholmerich J, Rogler G, Herfarth H. Profiling adipocytokine secretion from creeping fat in Crohn's disease. Inflamm Bowel Dis 12: 471-477, 2006. (Pubitemid 43916742)
38. Ricci MR, Levin BE. Ontogeny of diet-induced obesity in selectively bred Sprague-Dawley rats. Am J Physiol Regul Integr Comp Physiol 285: R610-R618, 2003.
39. Samad F, Loskutoff DJ. Tissue distribution and regulation of plasminogen activator inhibitor-1 in obese mice. Mol Med 2: 568-582, 1996. (Pubitemid 26353106)
40. Shimomura I, Funahashi T, Takahashi M, Maeda K, Kotani K, Nakamura T, Yamashita S, Miura M, Fukuda Y, Takemura K, Tokunaga K, Matsuzawa Y. Enhanced expression of PAI-1 in visceral fat: possible contributor to vascular disease in obesity. Nat Med 2: 800-803, 1996. (Pubitemid 26225097)
41. Siegmund B, Lehr HA, Fantuzzi G. Leptin: a pivotal mediator of intestinal inflammation in mice. Gastroenterology 122: 2011-2025, 2002. (Pubitemid 34651443)
42. Steiner AA, Romanovsky AA. Leptin: at the crossroads of energy balance and systemic inflammation. Prog Lipid Res 46: 89-107, 2006.
43. Tilg H, Moschen AR. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol 6: 772-783, 2006. (Pubitemid 44453463)
44. Trayhurn P, Bing C, Wood IS. Adipose tissue and adipokines - energy regulation from the human perspective. J Nutr 136: 1935S-1939S, 2006. (Pubitemid 43973602)
45. Tschop M, Heiman ML. Rodent obesity models: an overview. Exp Clin Endocrinol Diabetes 109: 307-319, 2001.
46. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444: 1027-1031, 2006. (Pubitemid 46018515)
47. Yamamoto K, Kiyohara T, Murayama Y, Kihara S, Okamoto Y, Funahashi T, Ito T, Nezu R, Tsutsui S, Miyagawa JI, Tamura S, Matsuzawa Y, Shimomura I, Shinomura Y. Production of adiponectin, an anti-inflammatory protein, in mesenteric adipose tissue in Crohn's disease. Gut 54: 789-796, 2005. (Pubitemid 40732095)
48. Zhao D, Zhan Y, Zeng H, Moyer MP, Mantzoros CS, Pothoulakis C. Ghrelin stimulates interleukin-8 gene expression through protein kinase C-mediated NF-kappaB pathway in human colonic epithelial cells. J Cell Biochem 97: 1317-1327, 2006.